Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure

Fig. 5

Cytokine assays of secretome from hESC-CMs or hiPSC-MSCs. a Angiogenic cytokines in CdM from hiPSC-MSCs (two cell lines) and hESC-CMs (two cell lines) with or without IFN-γ stimulation were measured by the cytokine assays. b–e The expression of angiopoietin-2, basic fibroblast growth factor (bFGF), leptin, and PDGF-BB from hiPSC-MSCs was much higher than from hESC-CMs with IFN-γ stimulation (*P < 0.05 vs. hESC-CMs, #P < 0.01 vs. hESC-CMs-IFN using one-way ANOVA with Bonferroni post hoc test)

Back to article page